Cancer diagnoses dropped sharply in Alberta during COVID-19 response

by Canadian Medical Association JournalCredit: Unsplash/CC0 Public DomainPandemic restrictions corresponded with a significant drop in diagnoses of breast, colorectal and prostate cancers as well

Updated on: February 20,2024 13

Cancer diagnoses dropped sharply in Alberta during COVID-19 response

by Canadian Medical Association JournalCredit: Unsplash/CC0 Public DomainPandemic restrictions corresponded with a significant drop in diagnoses of breast, colorectal and prostate cancers as well

Updated on:February 20,2024 13

Taxane-induced peripheral neuropathy in breast cancer: Frequent, clinically significant, and worse with paclitaxel

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainChemotherapy-induced peripheral neuropathy (CIPN)—nerve pain, tingling, or numbness in the hands or feet—is a common side effect of cer

Updated on: January 22,2024 12

Taxane-induced peripheral neuropathy in breast cancer: Frequent, clinically significant, and worse with paclitaxel

by SWOG Cancer Research NetworkCredit: Unsplash/CC0 Public DomainChemotherapy-induced peripheral neuropathy (CIPN)—nerve pain, tingling, or numbness in the hands or feet—is a common side effect of cer

Updated on:January 22,2024 12

New insight into combating drug-resistant prostate cancer

byUniversity of Eastern FinlandCredit:Nucleic Acids Research(2023). DOI: 10.1093/nar/gkad1126Recent research from the University of Eastern Finland sheds light on the significance of

Updated on: April 28,2024 0

New insight into combating drug-resistant prostate cancer

byUniversity of Eastern FinlandCredit:Nucleic Acids Research(2023). DOI: 10.1093/nar/gkad1126Recent research from the University of Eastern Finland sheds light on the significance of

Updated on:April 28,2024 0

Revolutionising radiotherapy: making a cornerstone cancer treatment more personal and powerful

by Cancer Research UKCredit: Cancer Research UK"We have a very powerful treatment which contributes to the cure of cancer in around a third of patients treated," says Professor David Se

Updated on: March 06,2024 14

Revolutionising radiotherapy: making a cornerstone cancer treatment more personal and powerful

by Cancer Research UKCredit: Cancer Research UK"We have a very powerful treatment which contributes to the cure of cancer in around a third of patients treated," says Professor David Se

Updated on:March 06,2024 14

Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment

byDana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.10.017For many patients with a condition that often precedes multiple myeloma, e

Updated on: January 02,2024 12

Immune system holds clues to patients with high-risk smoldering myeloma likely to benefit from treatment

byDana-Farber Cancer InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.10.017For many patients with a condition that often precedes multiple myeloma, e

Updated on:January 02,2024 12

AI model predicts breast cancer risk without racial bias, researchers report

by Radiological Society of North AmericaAbnormal mammogram. Credit: RSNAA deep learning artificial intelligence (AI) model that was developed using only mammogram image biomarkers has accurately

Updated on: June 24,2024 8

AI model predicts breast cancer risk without racial bias, researchers report

by Radiological Society of North AmericaAbnormal mammogram. Credit: RSNAA deep learning artificial intelligence (AI) model that was developed using only mammogram image biomarkers has accurately

Updated on:June 24,2024 8

New prostate cancer biomarkers provide hope to millions of men

byUniversity of South AustraliaCredit: AI-generated imageUniSA researchers have identified three new biomarkers for prostate cancer to help identify and differentiate potentially aggressive case

Updated on: January 12,2024 10

New prostate cancer biomarkers provide hope to millions of men

byUniversity of South AustraliaCredit: AI-generated imageUniSA researchers have identified three new biomarkers for prostate cancer to help identify and differentiate potentially aggressive case

Updated on:January 12,2024 10

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

by St. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainFibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The d

Updated on: March 30,2024 0

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

by St. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainFibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The d

Updated on:March 30,2024 0

International team discovers unique pathway for treating deadly children's brain cancer

by Steve Yozwiak,The Translational Genomics Research InstituteCredit: CC0 Public DomainAn international team of researchers led by Yale University, University of Iowa, and the Translational Geno

Updated on: March 12,2024 19

International team discovers unique pathway for treating deadly children's brain cancer

by Steve Yozwiak,The Translational Genomics Research InstituteCredit: CC0 Public DomainAn international team of researchers led by Yale University, University of Iowa, and the Translational Geno

Updated on:March 12,2024 19

Is assisted dying available equally to all in New Zealand?

by Jessica Young, Aida Dehkhoda and Jeanne Snelling,The ConversationCredit: Pixabay/CC0 Public DomainJust over two years ago, terminally ill New Zealanders were given the right to request a medi

Updated on: April 22,2024 15

Is assisted dying available equally to all in New Zealand?

by Jessica Young, Aida Dehkhoda and Jeanne Snelling,The ConversationCredit: Pixabay/CC0 Public DomainJust over two years ago, terminally ill New Zealanders were given the right to request a medi

Updated on:April 22,2024 15

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T

Updated on: March 30,2024 0

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T

Updated on:March 30,2024 0

Oncogenic driver FGFR3-TACC3 requires 5 coiled-coil heptads for activation and disulfide bonds for stability

by Impact Journals LLCFGFR3-TACC3 fusion proteins. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28359FGFR3-TACC3 represents an oncogenic fusion protein frequently identified in gliobl

Updated on: January 30,2024 10

Oncogenic driver FGFR3-TACC3 requires 5 coiled-coil heptads for activation and disulfide bonds for stability

by Impact Journals LLCFGFR3-TACC3 fusion proteins. Credit:Oncotarget(2023). DOI: 10.18632/oncotarget.28359FGFR3-TACC3 represents an oncogenic fusion protein frequently identified in gliobl

Updated on:January 30,2024 10